Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report

(NASDAQ:PGNY), Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced that it has entered into a […]

Net Zero Now Clears Key Milestone on 320-Acre Energy Campus, Accelerating Alberta’s Low-Carbon Data Center Infrastructure Build Out

Net Zero Now Ltd. (“Net Zero”) is pleased to announce the completion of environmental studies on its first energy campus in Alberta, a 320-acre site specifically selected to meet the infrastructure requirements and locational preferences of both electricity generation and data centers. With data centers applying for 16,229MW of load capacity from the electricity grid

Logan Golema Joins Alpha Liquid Terminal as Advisor to Drive AI and Blockchain Innovation in Research and Trading

New York, NY, July 08, 2025 (GLOBE NEWSWIRE) — Alpha Liquid Terminal (ALTx), a next-generation modular trading platform powered by AI agents, proudly announces the appointment of Logan Golema as an advisor. A trailblazer in the convergence of artificial intelligence and blockchain, Golema brings a powerful blend of technical vision and public-sector innovation to ALTx's

J.S. Held Acquires Chicago-based Turnaround & Restructuring Firm MorrisAnderson

Global consulting firm J.S. Held announces the acquisition of MorrisAnderson, a market leader in financial restructuring and operational consulting. The acquisition further strengthens J.S. Held's turnaround and restructuring, bankruptcy, transaction, and dispute advisory expertise that helps businesses overcome complex enterprise challenges and realize long-term, sustainable business value. https://mma.prnewswire.com/media/1824221/JS_Held_Logo.jpg MorrisAnderson clients benefit from deep technical, financial,

Syntiant Named 2025’s ‘Best Places to Work’ for Sixth Consecutive Year

IRVINE, Calif., July 08, 2025 (GLOBE NEWSWIRE) — Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it has been named one of 2025's “Best Places to Work in Orange County” by the Orange County Business Journal for the sixth year in a row. This continued recognition comes at a time of

Residential Pros Feel Confident in the Outlook for New Jobs, With Most Homeowners Expecting to Maintain Their Project Plans in 2025, According to Newly Released Data From STANLEY®

— Nearly three-quarters of residential pros surveyed say their clients are increasing the size of their 2025 projects — Costs of materials and labor are cited as top concerns as pros plan for the year — Many homeowners (93%) are embracing high-end design trends to upgrade their homes — High job satisfaction and fulfillment in

Canadian Investment Regulatory Organization Trading Halt – TAUR

The following issues have been halted by CIRO: Company: Taurus Gold Corp. CSE Symbol: TAUR All Issues: Yes Reason: Cease Trade Order Halt Time (ET): 7:45 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair

Analysis of the impact of Project2025’s technology policy on cryptocurrencies, will DEAL Mining be the most reliable safe haven?

San Francisco, CA, July 08, 2025 (GLOBE NEWSWIRE) — As the political winds in the United States are gradually influenced by “Project 2025”, this controversial policy blueprint promoted by conservative think tanks has raised a lot of concerns about financial surveillance, digital asset regulation, and centralized intervention. The blueprint proposes measures to expand administrative power

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

(NASDAQ:ICU), DENVER, July 08, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that the QUELIMMUNE therapy has been adopted for use by the nationally recognized Texas Children's Hospital. The QUELIMMUNE therapy

Scroll to Top